Vallota E H, Forristal J, Spitzer R E, Davis N C, West C D
J Clin Invest. 1971 Mar;50(3):552-8. doi: 10.1172/JCI106524.
Serum levels of complement components and of C3 nephritic factor (C3NeF) were measured serially in two patients with membrano-proliferative glomerulonephritis who were subjected to bilateral nephrectomy and maintained by peritoneal dialysis for 2 wk before renal transplantation. In both patients, low levels of C3 and high levels of preformed alpha 2D, a C3 breakdown product, were present before nephrectomy and remained essentially unchanged during the anephric period. With transplantation, C3 levels rose towards normal and alpha 2D disappeared from the serum. The serum of both patients contained detectable amounts of C3NeF, a factor which has been shown to react with a cofactor found in normal serum to form an enzyme, designated C3 lytic nephritic factor (C3LyNeF), which will cleave C3 to form the breakdown products, beta1A and alpha 2D. The level of C3NeF was high in one patient before nephrectomy, increased somewhat during the anephric period, and fell after transplantation. In the other patient, the C3NeF level was initially lower, remained relatively constant during the anephric period, and was not significantly affected by transplantation. In both patients, levels of C4 and C5 were either normal or elevated over the period of the study and bore no relationship to the C3 level. The following conclusions can be drawn from the data. The high levels of alpha 2D during the anephric period and the disappearance of this protein as C3 levels approach normal at the time of transplantation indicate that the low C3 levels were largely the result of C3 breakdown rather than diminished synthesis. The presence of C3NeF in detectable amounts in both patients suggest that C3LyNeF, formed by the reaction of C3NeF and cofactor, was responsible for the low C3 levels. Finally, the lack of effect of nephrectomy on C3, alpha 2D, and C3NeF levels indicate that the site of C3 breakdown was extrarenal and that C3NeF and cofactor are at least in large part of extrarenal origin.
对两名膜增生性肾小球肾炎患者进行了连续血清补体成分及C3肾炎因子(C3NeF)水平检测。这两名患者接受了双侧肾切除术,并在肾移植前接受了2周的腹膜透析维持治疗。在两名患者中,肾切除术前C3水平较低,而预先形成的α2D(一种C3裂解产物)水平较高,且在无肾期基本保持不变。随着移植的进行,C3水平升至正常,α2D从血清中消失。两名患者的血清中均含有可检测到的C3NeF,该因子已被证明可与正常血清中发现的一种辅助因子反应形成一种酶,称为C3裂解性肾炎因子(C3LyNeF),它能裂解C3形成裂解产物β1A和α2D。一名患者肾切除术前C3NeF水平较高,在无肾期有所升高,移植后下降。另一名患者,C3NeF水平最初较低,在无肾期保持相对稳定,且未受到移植的显著影响。在两名患者中,C4和C5水平在研究期间要么正常要么升高,与C3水平无关。从这些数据可以得出以下结论。无肾期α2D水平较高,而在移植时随着C3水平接近正常该蛋白消失,这表明低C3水平主要是C3裂解的结果而非合成减少。两名患者血清中均可检测到C3NeF,这表明由C3NeF与辅助因子反应形成的C3LyNeF是导致低C3水平的原因。最后,肾切除术对C3、α2D和C3NeF水平无影响,这表明C3裂解的部位在肾外,且C3NeF和辅助因子至少在很大程度上来源于肾外。